The purpose of this study is to determine the appropriate dosage, safety and effectiveness of the study drug, IPN01194 in adults with advanced solid tumours. The participants in this study will have advanced solid tumours. 'Advanced solid tumours' refers to cancers that can occur in several places, including cancers in organs or tissues that have spread from their original site to nearby tissues or other parts of the body. In this study, all participants will receive the study drug, which will be taken by mouth (orally).
Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Solid Tumor
The purpose of this study is to determine the appropriate dosage, safety and effectiveness of the study drug, IPN01194 in adults with advanced solid tumours. The participants in this study will have advanced solid tumours. 'Advanced solid tumours' refers to cancers that can occur in several places, including cancers in organs or tissues that have spread from their original site to nearby tissues or other parts of the body. In this study, all participants will receive the study drug, which will be taken by mouth (orally).
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
-
The Angeles Clinic and Research Institute - California, Los Angeles, California, United States, 90025
UC San Diego Health System - La Jolla, San Diego, California, United States, 92037
Yale Cancer Center - New Heaven, New Haven, Connecticut, United States, 06510
Sarah Cannon Research Institute (SCRI) - Nashville, Nashville, Tennessee, United States, 37203
Virginia Cancer Specialist, Fairfax, Virginia, United States, 22031
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Ipsen,
Ipsen Medical Director, STUDY_DIRECTOR, Ipsen
2028-03-20